Evaluation of Side Effects of Mitotane
NCT00568139 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 400
Last updated 2026-05-07
Summary
Mitotane is standard therapy in the treatment of adrenocortical carcinoma. However, many adverse effects are not well documented. Therefore, we are aiming at collecting data about adverse effects in patients treated with mitotane
Conditions
- Adrenocortical Carcinoma
Sponsors & Collaborators
-
University of Wuerzburg
lead OTHER
Principal Investigators
-
Martin Fassnacht, MD · University of Wuerzburg
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2008-01-31
- Primary Completion
- 2027-12-31
- Completion
- 2029-12-31
Countries
- Germany
Study Locations
More Related Trials
-
Evaluate the Effect of Entrectinib on the Pharmacokinetics of Midazolam in Cancer Patients
NCT03330990 ·Status: COMPLETED ·Phase: PHASE1
-
Multicentre Real-life Data Collection Study With CareMin650™ in the Prevention and Treatment of Oral Mucositis and Radio- and/or Chemo-induced Dermatitis
NCT07054528 ·Status: ACTIVE_NOT_RECRUITING
-
The Addition of Metformin to Definitive Radiotherapy in Patients With Stage III NSCLC
NCT04170959 ·Status: TERMINATED ·Phase: PHASE2
-
A Phase I Topotecan Study in Subjects With Cancer and Impaired Renal Function
NCT00483860 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase I Clinical Study on a New Oral Pentamidine Formulation in Hepatocellular Carcinoma
NCT02210182 ·Status: COMPLETED ·Phase: PHASE1
-
Anamorelin Hydrochloride, Physical Activity, and Nutritional Counseling in Decreasing Cancer-Related Fatigue in Patients With Incurable Metastatic or Recurrent Solid Tumors
NCT03035409 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Analyses of Human Samples Collected in Clinical Trials
NCT00339664 ·Status: COMPLETED
-
Microvascular Function in Patients Undergoing 5-Fluorouracil Chemotherapy
NCT04042298 ·Status: COMPLETED
-
Retrospective Analysis of a Drug-Metabolizing Genotype in Cancer Patients and Correlation With Pharmacokinetic and Pharmacodynamics Data
NCT00341939 ·Status: COMPLETED
-
Acetylamantadine Excretion by Cancer Patients
NCT02277938 ·Status: UNKNOWN
-
Alpha Lipoic Acid to Decrease Pain and Side Effects in Concurrent Treatment of HNSCC
NCT04042935 ·Status: COMPLETED ·Phase: PHASE1
-
Weekly Topotecan in Combination With Carboplatin in Two Different Schedules for Refractory and/or Advanced Solid Tumors
NCT00193583 ·Status: COMPLETED ·Phase: PHASE1
-
Study of Cytoreductive Surgery and Hyperthermic Intrathoracic Pleural Chemotherapy (HITC) With Escalating Doses for Children and Adolescents With Unilateral Pleural Malignancy
NCT01998529 ·Status: COMPLETED ·Phase: PHASE1
-
Phase I Study of Intrathecal Topotecan
NCT00001333 ·Status: COMPLETED ·Phase: PHASE1
-
Intratumoral Cancer Chemotherapy Through a Flexible Bronchoscope as an Adjunct to Brachytherapy
NCT00379665 ·Status: COMPLETED ·Phase: PHASE2
-
ULTRATRACE Iobenguane I 131 in Patients With Malignant Pheochromocytoma, Paraganglioma, or Metastatic Carcinoid
NCT00339131 ·Status: COMPLETED ·Phase: PHASE1
-
Wearable Sensors and Molecular Omics to Detect and Mitigate Cell Therapy Adverse Events
NCT05123001 ·Status: COMPLETED
-
Clinical Study of Metronomic Oral Cyclophosphamide in Patients With Advanced Sarcomas
NCT01716689 ·Status: COMPLETED ·Phase: PHASE2
-
Collaborative Network to Take Responsibility for Oral Anticancer Therapy
NCT02861209 ·Status: UNKNOWN ·Phase: NA
-
Topotecan Pharmacokinetic Characterization Study
NCT00361803 ·Status: COMPLETED ·Phase: PHASE1
-
Corticosteroids for Cancer Pain
NCT00676936 ·Status: COMPLETED ·Phase: PHASE3
-
SENS-401 to Prevent the Ototoxicity Induced by Cisplatin in Adult Subjects With a Neoplastic Disease
NCT05628233 ·Status: COMPLETED ·Phase: PHASE2
-
Docetaxel in Treating Patients With Solid Tumors and Abnormal Liver Function
NCT00002901 ·Status: COMPLETED ·Phase: PHASE1
-
Optimization of the Targeted Anticancer Therapies
NCT04484064 ·Status: RECRUITING ·Phase: NA
-
Safety and Effectiveness of Combretastatin A-4 Phosphate Combined With Chemotherapy in Advanced Solid Tumors
NCT00113438 ·Status: COMPLETED ·Phase: PHASE2